Key Segments:
By Product
-
Blood Glucose Monitoring
-
Infectious Disease Monitoring
-
Cardiometabolic Disease Testing
-
Hematology Testing
-
Others
By Sample
-
Blood
-
Nasal and Oropharyngeal Swabs
-
Urine
-
Others
By End- User
-
Hospital Bedside
-
Physican’s Office Lab
-
Urgent Care & Retail Clinics
-
Home & Self Testing
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
Egypt
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Abbott, Roche, Siemens Healthineers, Danaher, bioMérieux, and QuidelOrtho.
Key opportunities include home testing, molecular diagnostics, digital connectivity, and decentralized healthcare expansion.
Market growth is driven by rapid testing demand, chronic diseases, and decentralized diagnostics adoption.
Blood glucose monitoring dominated the market due to widespread diabetes testing and self-monitoring demand.
North America dominated in 2025, supported by advanced healthcare infrastructure and high diagnostic adoption.
